20.09 USD
-0.31 (-1.52%)
20.11 USD
+0.02 (+0.1%)
ChartMill assigns a Buy % Consensus number of 89% to ZBIO. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 41.57. This target is 106.89% above the current price.
- ZBIO was analyzed by 14 analysts. The buy percentage consensus is at 89. So analysts seem to be very confident about ZBIO.
- In the previous month the buy percentage consensus was at a similar level.
- ZBIO was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-06 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2025-12-22 | Wedbush | Reiterate | Outperform -> Outperform |
| 2025-11-26 | Evercore ISI Group | Initiate | Outperform |
| 2025-11-13 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-10-28 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-10-28 | Citigroup | Maintains | Buy -> Buy |
| 2025-10-28 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-10-09 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-10-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-05-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-20 | Wedbush | Initiate | Outperform |
| 2025-03-12 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-03-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-04 | Wolfe Research | Initiate | Outperform |
| 2024-12-16 | HC Wainwright & Co. | Initiate | Buy |
| 2024-12-11 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2024-12-03 | Guggenheim | Reiterate | Buy |
| 2024-10-08 | Guggenheim | Initiate | Buy |
| 2024-10-08 | Morgan Stanley | Initiate | Overweight |
| 2024-10-08 | Citigroup | Initiate | Buy |
| 2024-10-08 | Jefferies | Initiate | Buy |
ZENAS BIOPHARMA INC / ZBIO FAQ
What is the price target for ZBIO stock?
14 analysts have analysed ZBIO and the average price target is 41.57 USD. This implies a price increase of 106.89% is expected in the next year compared to the current price of 20.09.
What is the consensus rating for ZENAS BIOPHARMA INC (ZBIO) stock?
The consensus rating for ZENAS BIOPHARMA INC (ZBIO) is 88.5714 / 100 . This indicates that analysts generally have a positive outlook on the stock.